CD1d is an MHC class I-like, ␤2-microglobulin-associated protein, constitutively expressed by antigenpresenting cells and some epithelial cells, which is recognized by NKT cells, a subpopulation of T cells. CD1d-dependent NKT cells confer protection in immune-mediated disorders, but whether these cells modulate the development of glomerulonephritis is unknown. Experimental crescentic glomerulonephritis was induced by administering anti-glomerular basement membrane antibodies to NKT cell-deficient (CD1d Ϫ/Ϫ ) and wild-type mice. Compared with wild-type mice, NKT cell-deficient mice had an accelerated course of glomerulonephritis measured by renal function and crescent formation, and this was abrogated by adoptive transfer of NKT cells. Reconstitution with NKT cells also attenuated intraglomerular expression of TGF-␤1 and decreased phosphorylation of the transcription factors NF-B and IB. Adopted transfer of fluorescence-labeled NKT cells demonstrated their distribution to glomeruli damaged by anti-glomerular basement membrane antibodies but not to the tubulointerstitium. The chemokine CXCL16, which is the ligand for CXCR6 on NKT cells, was upregulated in glomeruli after induction of glomerulonephritis, and NKT cells were present in the same glomeruli. In vitro, NKT cells inhibited LPS-stimulated proliferation of mesangial cells, an affect that was reduced by co-current treatment with an anti-CXCL16 monoclonal antibody. In summary, these findings highlight the regulatory capacity of CD1d-dependent NKT cells in experimental glomerulonephritis and suggest that CXCL16 is involved in the recruitment of these cells to the site of injury.
Despite the emerging burden of diabetic nephropathy, glomerulonephritis (GN) remains a major cause of chronic renal failure and ESRD requiring dialysis and transplantation. 1, 2 Although the exact nature of the pathogenesis of GN is still unknown, immune complex-mediated inflammatory responses have been suggested as central pathogenic mechanism. 3 Glomerular crescent formation, the hallmark of severe and rapidly progressive immune renal injury, is characterized by the accumulation of T cells, macrophages, and fibrin in glomeruli. 4 -6 Among the various animal models of GN, experimental crescentic GN (ecGN) induced by anti-glomerular basement membrane (anti-GBM) antibodies has been widely studied and seems to be the most similar counterpart of the human disease. [7] [8] [9] CD1d is a nonclassical MHC class I-like, ␤2-microglobulin-associated protein constitutively expressed by antigen-presenting cells and some epithelial cells. CD1d is recognized by a subpopulation of T cells, many of which express markers typical of NK cells and have been identified as a unique population NKT cells. 10 -12 A major fraction of CD1d-restricted T cells recognize glycolipid antigen through an invariant T cell receptor (TCR) ␣ chain. CD1d-dependent NKT cells using this invariant TCR have regulatory functions in innate and adaptive immune responses. 12, 13 They secrete large amounts of IL-4 and IFN-␥ upon stimulation with their TCR. In animal models, NKT cells have been reported to affect the development and progression of diabetes, 14 experimental autoimmune encephalitis, 15 and systemic lupus erythematosus. 16 NKT cells also have been exploited in several organ transplantation systems. They are critical for the induction of antigen-specific tolerance to xenogeneic islet cells induced by anti-CD4 mAb. 17 NKT cells also mediate the tolerogenic action in an allogeneic heart graft model 18, 19 and in an allogeneic islet graft model. 20 Recently, the role of regulatory cells such as CD4
ϩ CD25 ϩ regulatory T cells was enlightened in autoimmune as well as in alloimmune disease. 21, 22 Although the mechanism by which CD4 ϩ
CD25
ϩ regulatory T cells regulate immune response remains controversial, cell-to-cell contact inhibition seems to be critical to exert immunosuppression. 23 Wolf et al. 24 reported the role of regulatory function of CD4 ϩ
ϩ T cells in an ecGN model of mice, but the role of regulatory function of NKT cells in ecGN has not been evaluated thoroughly. The objective of this study was to evaluate the regulatory capacity of CD1d-dependent NKT cells and molecular mechanisms of the reduction of glomerular injury exerted by NKT cells using an ecGN model in mice. Ϫ/Ϫ , respectively; P Ͻ 0.05; Figure 1A ), whereas the adoptive transfer of sorted NKT cells into B6.CD1d Ϫ/Ϫ mice lessened the amount of proteinuria and protected the deterioration of renal function similar to or better than wild-type mice (NKT cell transferred B6.CD1d Ϫ/Ϫ ; protein/creatinine 87.2 Ϯ 6.46 mg/mg, BUN 32 Ϯ 2.5 mg/dl). The antiproteinuric effect of NKT cells on B6.CD1d Ϫ/Ϫ mice was dosage dependent on the numbers of cells transferred ( Figure 1B) . Conversely, NKT cell repletion on B6.CD1d Ϫ/Ϫ mice after the induction of ecGN (i.e., 1 d after the disease induction) did not show the significant protective effect (Supplemental Figure 2) . For examination of the protective role of NKT cells in wild-type mice, sorted NKT cells were adoptively transferred into wild-type mice and ecGN was induced. The overpopulation of NKT cells showed the beneficial effects on the degree of proteinuria and deterioration of renal function (protein/creatinine 61.2 Ϯ 3.89 6 , E; NKT2: 2 ϫ 10 6 /mouse) were adoptively transferred into B6.CDd Ϫ/Ϫ on days Ϫ1 and 0 (day 0 being the day of 3-mg anti-GBM Ab injection). NKT cell repletion on B6.CDd Ϫ/Ϫ after the induction of ecGN attenuated the severity of GN in terms of the amount of proteinuria and the deterioration of renal function, and the protective effect lasted for 3 wk (n ϭ 8 per group; *P Ͻ 0.05, NKT1 versus NKT2). (C) Protective role of NKT cells in wild-type mice. Sorted NKT cells were adoptively transferred into B6 and B6.CD1d mg/mg, BUN 42 Ϯ 7.3 mg/dl; P Ͻ 0.05, respectively, compared with B6; Figure 1C ).
RESULTS

Deficiency of
Histologic Changes and Presence of NKT Cells
On histologic examinations, glomerular crescents developed in more than 40% of glomeruli in B6 mice, but in B6.CD1d Ϫ/Ϫ mice, the crescent formation was more prominent compared with wild-type mice (45 Ϯ 5.0 versus 83 Ϯ 2.5%, B6 versus B6.CD1d Ϫ/Ϫ , respectively; P Ͻ 0.05). Again, the repletion of NKT cells attenuated the histologic changes (i.e., less crescent formations after the adoptive transfer of NKT cells into B6.CD1d
Ϫ/Ϫ mice [25 Ϯ 5.0%]; Figure 2A ). To assess the molecular interactions according to presence or absence of NKT cells in host, we probed TGF-␤1 using immunohistochemistry. The expression patterns of TGF-␤1 were parallel with the histologic changes. TGF-␤1 was expressed most prominently in B6.CD1d
Ϫ/Ϫ mice after the induction of ecGN, and its expression was downmodulated with the repletion of NKT cells into B6.CD1d
Ϫ/Ϫ mice similar to level in the wild-type mice (TGF-␤1 ϩ glomeruli; 45 Ϯ 5.0 versus 86 Ϯ 4.0 versus 50 Ϯ 5.0%, B6 versus B6.CD1d Ϫ/Ϫ versus B6.CD1d Ϫ/Ϫ ϩ NKT cells, respectively; P Ͻ 0.05; Figure 2B ). Next, we assessed the notion that NKT cells were involved in the active inflammation of ecGN. Fluorescence-tagged, sorted NKT cells were introduced into mice with the induction of anti-GBM Ab. The transferred NKT cells were detectable in 30% of glomeruli examined, and they were present in the glomeruli where Ab was deposited, but the transferred cells were not found in the tubulointerstitial area ( Figure 2C ). We tried to confirm again the presence of NKT cells at the site of interest again using mRNA quantification for V␣14 that is specific for NKT cells. As shown in Figure  2D , expression of V␣14 was null in B6.CD1d
Ϫ/Ϫ mice after PBS or anti-GBM Ab injection, but with the adoptive transfer of NKT cells into B6.CD1d
Ϫ/Ϫ mice with the induction of ecGN, V␣14 mRNA in renal tissue was upregulated in 2 h. the interactions between the phosphorylated transcriptional factors ( Figure 3B ). To know the protective mechanisms of NKT cells, we assessed the changes of complement deposition and cellular infiltrations depending on the presence and absence of NKT cells in ecGN. With the induction of ecGN, complement 3 (C3) depositionwasevidentalongtheglomerularcapillarywallsandwasmore prominent in B6.CD1d Ϫ/Ϫ mice, but the overpopulation of NKT cells in B6 mice and the repletion of NKT cells in B6.CD1d
Ϫ/Ϫ mice markedly inhibited C3 deposition along the glomerular capillary walls where anti-GBM Ab deposited ( Figure 3C ). Again, macrophage/monocyte infiltration after the induction of ecGN showed the similar kinetics as complement deposition depending on the presence or absence of NKT cells in the hosts ( Figure 3D ).
Cytokines are Differentially Regulated by NKT Cells in ecGN
To test the expressions of cytokines that may affect the intraglomerular immune responses by NKT cells, we quantified mRNA levels using real-time PCR after 7 d of disease induction. With the development of ecGN in wild-type mice, TGF-␤1, IFN-␥, IL-4, and IL-10 were upregulated, and these molecular changes were accentuated in B6.CD1d
Ϫ/Ϫ mice except IL-4 and IL-10. The expressions of IL-4 and IL-10 were significantly suppressed in B6.CD1d
Ϫ/Ϫ mice with the development of ecGN; however, these changes were reversed with the repletion of NKT cells into B6.CD1d
Ϫ/Ϫ mice ( Figure 4A ). To test the relationship between the changes of cytokine expression and NKT cell activation, we stimulated D32.D3, an NKT cell line, with ␣-GalCer. As shown in Figure 4B , NKT cells produced IL-4 and IL-10 by activation.
Expression of CXCL16 Is Parallel with NKT Cell Recruitment
Next, we tried to evaluate the renal factor that might recruit the activated NKT cells into the affected kidney. CXCL16, which is the ligand for CXCR6, is expressed on NKT cells, and has a unique role to maintain allograft tolerance, 19 was probed in our model. Intraglomerular CXCL16 was not expressed in wild-type as well as in B6.CD1d Ϫ/Ϫ mice but was upregulated after the induction of ecGN in both types of mice ( Figure 5A ). When we traced the CM-DiI-tagged NKT cells after ecGN induction, the adoptively transferred NKT cells were found in the affected glomeruli along with the expression of CXCL16 ( Figure 5B ). In B6.CD1d Ϫ/Ϫ mice, the expression of CXCL16 reached the peak in 24 h after the induction of ecGN ( Figure 5C ), and in the adoptive transfer of NKT cells either into B6 or B6.CD1d Ϫ/Ϫ mice, the expression of CXCL16 was prominently upregulated with the induction of ecGN, thereby recruiting more NKT cells into the site of inflammation ( Figure 5D ).
Direct Regulatory Capacity of NKT Cells on Mesangial Stimulation
Finally, we further evaluated the regulatory capacity of NKT cells using an in vitro culture system. The mesangial cells were proliferated with the stimulation of LPS as assessed by MTS assay. Co-culture with D32.D3, that is NKT cell line, did not affect the proliferation of mesangial cells, but the activated NKT cells inhibited the proliferation of mesangial cells initiated by LPS stimulation; however, the inhibition of the interaction between NKT cells and mesangial cells using blocking Ab suppressed the regulatory capacity of NKT cells against exogenous stimuli ( Figure 6A ). The interaction between the activated NKT cells and mesangial cells was evident because the expressions of IL-4 and IL-10 were downregulated with the addition of blocking anti-CXCL16 mAb ( Figure 6B ).
DISCUSSION
In this study, we evaluated the regulatory capacity of CD1d-dependent NKT cells in ecGN. We showed that NKT cells had 4 /well) was activated by ␣-GalCer (200 ng/ml) for 16 h. The culture medium was changed with/without LPS (2 g/ml). Each condition was done in triplicate, and this represents one of three independent experiments (**P Ͻ 0.01).
BASIC RESEARCH www.jasn.org a renoprotective effect against Ab-mediated inflammation by differential expression of various cytokines and by active engagement of NKT cells at the site of inflammation. Furthermore, we demonstrated that the intraglomerular expression of CXCL16 was associated with the recruitment of NKT cells to the site of inflammation, thus enabling the immunoregulatory activity.
Despite the emerging burden of diabetic nephropathy, GN remains a major cause of chronic renal failure and ESRD requiring dialysis and transplantation. 1,2 Among various factors causing GN, a central role for T cells, not only in providing help for production of Ig but also in directing cellular immune mechanisms, is now recognized in GN. 25 Studies in murine models have confirmed the dependence of crescentic GN in Th1 cytokines and the ability of interventions that alter the balance of Th1/Th2 cytokines to modulate crescentic injury. Genetic deletion or blocking cytokines with inhibitory Ab lessened the disease severity. 25 Recently, the role of cells that have regulatory function has been focused. Among them, CD4 ϩ CD25 ϩ regulatory cells (Treg) are intensively investigated in the maintenance of tolerance in rodents and human. 21 The role of Treg has been investigated in experimental GN, and the potent suppressive activity attenuating the severity of deterioration of renal function as well as histologic changes has been shown 24 ; however, the regulatory capacity of NKT cells on glomerulopathy has not been evaluated thoroughly. Although NKT cells emerge as important regulators of the immune response, functionally distinct cell types are regarded as NKT cells. Among them, CD1d-dependent NKT cell is the major cell type expressing NK1.1 and TCR. 26 These cells have distinctive roles in immune responses, such as in the maintenance of peripheral tolerance, 27 and in the protection from autoimmune disease. 14 Previously, we investigated the direct role of CD1d-dependent NKT cells using a skin graft model and demonstrated that the regulatory capacity was dependent on the magnitude of the antigenic strength. 28 In this study, we have shown the regulatory capacity of NKT cells in ecGN: Absence of NKT cells aggravated the glomerulopathy functionally as well as histologically, and repletion of NKT cells attenuated the severity of disease. The protective role of NKT cells was dependent on the number of cells reconstituted. Conversely, the protective effect of NKT cells was not evident when the cells were transferred after the induction of disease (Supplemental Figure 2) . As shown in Figure 3 , the presence of NKT cells prevented the deposition of C3 and monocyte infiltration, thereby lessening the immunologic downstream cascade. We assume that the readiness of NKT cells in host is critical for the control of inflammation. We further confirmed the notion that NKT cells might exert the suppressive capacity at the site of inflammation. The transferred NKT cells were traced using fluorescence labeling and real-time PCR technique. As shown in Figure 2 , C and D, the transferred cells localized at the site of inflammation. We suggest that the tissue damage after Ab injection initiated NKT cell activation and the remote activation pathway applied to NKT cells (i.e., the endogenous glycolipid released after tissue damage was presented by CD1d molecules on the host antigenpresenting cells and in turn activated NKT cells in the remote place [e.g., liver]). Activated NKT cells secreted immune-modulating soluble mediators in situ and directly migrated to and acted at the site of inflammation. 28, 29 Previous studies by us and other researchers on the immunoregulatory functions of NKT cells have emphasized the key role of various cytokines. IL-4, IL-10, and TGF-␤1 seemed to mediate the immunoregulatory activity of NKT cells in different experimental models. 28, 30, 31 Although TGF-␤1 is a multifunctional cytokine that has diverse effects on a variety of cell types, blockade of its signaling prevented the development of ecGN, 32 and the expression of TGF-␤1 was positively correlated with the severity of ecGN 6 as in this study. With the development of ecGN, inflammatory pathways were activated and it was reflected in the upregulation of phosphorylated p65 in our experiment. The absence of NKT cells that exert immunosuppressive activity accentuated the activation of transcriptional factors. The expressions of various cytokines were parallel with the changes of transcriptional factors. In our model, IL-4 and IL-10 expressions were repressed in NKT cell-deficient mice, and the repletion of NKT cells made the cytokine profiles similar to wildtype hosts. These findings are consistent with the previous report that NKT cells secreted IL-4 and IL-10 robustly with the activation. 10, 28 Recently, it was reported that CXCL16/CXCR6 pathway was critical for the NKT cell trafficking and CXCL16 upregulation was associated the induction of allograft tolerance. 19 CXCL16 was discovered as a ligand for CXCR6 that is expressed on activated T and NKT cells and is a membranebound chemokine. 33, 34 We hypothesized that renal injury mediated by anti-GBM Ab might induce the intraglomerular upregulation of CXCL16. As shown in Figure 5A , CXCL16 was BASIC RESEARCH www.jasn.org expressed evidently by the induction of ecGN regardless of the presence of NKT cells. Previously, the expression of CXCL16 was studied in immune cells such as macrophages and dendritic cells. 35 Also, it was reported that nonimmune cells such as smooth muscle cells and keratinocytes expressed CXCL16. 34, 36 In our experiment, we found that CXCL16 was expressed on the damaged glomerular cells, probably mesangial cells, but not on intact glomerular cells, and the development of glomerulopathy recruited NKT cells into affected kidney, where CXCL16 was expressed.
To our knowledge, this is the first demonstration that CD1d-dependent NKT cells lead to the prevention of ecGN, and further studies of the combined use of TCRJ␣18 Ϫ/Ϫ and CD1d Ϫ/Ϫ mice should be conducted to delineate the functional diversities of NKT cells in vivo. We believe that an understanding of the way in which these cells work could have therapeutic implications for the treatment of human GN.
CONCISE METHODS
Experimental Animals
Male C57BL/6 (B6; approximately 7 to 8 wk old) mice were purchased from Orient Company (Seoul, Korea). CD1d Ϫ/Ϫ mice were purchased from Jackson Laboratories (Bar Harbor, ME) and backcrossed to C57BL/6 background for 10 generations (B6.CD1d 
Induction of ecGN
Anti-GBM Ab was prepared from the serum of a rabbit immunized against homogenized murine renal cortex in complete Freund's adjuvant (Sigma, St. Louis, MO). GN was initiated by the intravenous injection of 3 mg of rabbit anti-GBM Ab into 8-to 10-wk-old male C57BL/6 or B6.CD1d Ϫ/Ϫ mice as detailed in online data supplements.
Adoptive Transfer of Hepatic NKT Cells
For reconstitution of NKT cells, hepatic mononuclear cells from B6 mice were prepared as detailed in online data supplements.
Quantitative Real-Time PCR
Renal tissues were harvested from mice 7 d after disease induction, and the cytokine expression profile was assayed with real-time PCR as detailed in online data supplements.
Histologic Analysis
For assessment of their light microscopic appearance, 4-m paraffin sections were stained with periodic acid-Schiff reagent. For grading the induced GN, the numbers of glomeruli forming crescent were counted in a blinded manner. A minimum of 50 glomeruli per mouse kidney were evaluated, and the mean value was used as representative for mouse (see online data supplements).
Western Blot Analysis
Kidneys were harvest at days 7 after induction of ecGN. Western immunoblot analysis of kidney was performed using the primary Ab against to phosphorylated p65, IB␣, TGF-␤1, and ␤-actin to show specificity to their respective antigens as detailed in online data supplements.
Confocal Microscopic Examination
Confocal microscopy was performed by using a LSM510 META laser confocal microscope (Carl Zeiss, Jena, Germany), as described in online data supplements.
Mesangial Cell Proliferation Assay
See online data supplements.
Cytokine Array (Bio-Plex Cytokine Assay)
Mesangial cells were co-cultured with NKT hybridoma cell (5 ϫ 10 4 / well; DN32.D3; ATCC, Manassas, VA). NKT cell was activated by ␣-GalCer (200 ng/ml), and supernatants were harvested after 16 h of culture. For blocking assay, cells were incubated with an anti-CXCL16 neutralizing antibody (R&D Systems, Minneapolis, MN) for 1 h at 37°C before addition of ␣-GalCer. Supernatants were then assayed for cytokines using a multiplex cytokine bead array system (Bio-Plex; Bio-Rad, Hercules, CA) according to the manufacturer's instructions (see online data supplements).
Statistical Analysis
The results are expressed as means Ϯ SD or means Ϯ SEM where appropriate. Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA). For comparison of more than two groups, the one-way ANOVA statistical analysis using Tukey test was performed. P Ͻ 0.05 was used to indicate a statistically significant difference.
